A epidemiologia da anafilaxia no Brasil: enquanto o CID 11 não chega
Gustavo Silveira Graudenz; Helena Landim Cristóvão
References
1. Tang ML, Osborne N, Allen K. Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol. 2009 Aug;9(4):351-6.
2. Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013 Nov 1;68(11):1353-61.
3. Wood RA, Camargo CA, Lieberman P, Sampson HA, Schwartz LB, Zitt M, et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014 Feb 1;133(2):461-7.
4. da Silva EGM, Morato-Castro FF. Epidemiology of anaphylaxis. Brazilian J Allergy Immunol. 2014;2(1):21-7.
5. Tanno LK, Chalmers RJG, Calderon MA, Aymé S, Demoly P. Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization’s (WHO) International Classification of Diseases (ICD-11). Orphanet J Rare Dis. 2017 Dec 16;12(1):53.
6. Serpa FS, Cruz ÁA, Condino-Neto A, Silva EC, Franco JM, Mello JM, et al. O atendimento médico de pacientes com doenças imunoalérgicas no Brasil: reflexões e propostas para a melhoria – Carta de Belo Horizonte. Arq Asma Alerg Imunol. 2017;1(4):327‑34.
